US Stock Futures Drop Ahead Of Jobless Claims Report

Loading...
Loading...
Pre-open movers
US stock futures traded lower in early pre-market trade, ahead of jobless claims data. Data on weekly jobless claims will be released at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average dipped 47 points to 17,011.00, while the Standard & Poor's 500 index futures fell 5.40 points to 1,989.60. Futures for the Nasdaq 100 index dropped 8.50 points to 4,084.50.
A Peek Into Global Markets
European markets were mixed today, with the Spanish Ibex Index dropping 0.20%, STOXX Europe 600 Index gaining 0.18%. German DAX 30 index rose 0.18%, French CAC 40 Index fell 0.05% and London's FTSE 100 Index dropped 0.17%. In Asian markets, Japan's Nikkei Stock Average gained 0.76%, Hong Kong's Hang Seng Index dipped 0.17%, China's Shanghai Composite Index fell 0.29% and India's BSE Sensex dropped 0.23%. China's consumer price index climbed 2% y/y in August, while the producer price index dropped 1.2% y/y in August. Australia's unemployment rate fell to 6.1% in August, versus 6.4% in July.
Broker Recommendation
Analysts at Baird upgraded Vera Bradley
VRA
from Neutral to Outperform. The target price for Vera Bradley has been raised from $26 to $28. Vera Bradley's shares closed at $22.74 yesterday.
Breaking news
  • Shares of Lululemon Athletica LULU surged around 6.8% in pre-market trading after the company reported better-than-expected second-quarter earnings. To read the full news, click here.
  • R. R. Donnelley & Sons Company RRD announced today that it has been awarded a $60 million multi-year agreement by Crain Communications that significantly expands the companies' relationship through 2020. To read the full news, click here.
  • AbbVie ABBV today announced results from a Phase 3 pivotal study demonstrating that HUMIRA® (adalimumab) is effective in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa (HS), specifically the number of abscesses and inflammatory nodules. To read the full news, click here.
  • CME Group CME today announced that it has appointed Cees Vermaas as Managing Director and CEO of CME Europe Limited, its London-based derivatives exchange, effective 2 January 2015. To read the full news, click here.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsEurozoneFuturesGlobalPre-Market OutlookMarketsApparel, Accessories & Luxury GoodsBairdConsumer DiscretionaryUS Stock Futures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...